Tag:#Columbia Care

From Flowers To Pharma – How Europe Is Forging Its Own Medicinal Cannabis Identity

As Europe embraces medicinal cannabis the continent’s prescribing landscape is developing different characteristics to that of the US. AFTER picking up their script from a...

Human Trial Showing CBD Safe A Boost For Industry In Battles With Regulators

RESULTS from a major US trial over 800 people over the past seven months found CBD use has zero impact on the liver. In March,...

Fifteen Company Consortium For Europe’s Largest – £1m – CBD Toxicity Trial

EUROPE’S largest ever trial designed to establish the safety of CBD products has been announced with 15 participating companies. The trial, which has been organised...

Latest news

MGC Pharmaceuticals Releases Update On CimetrA Clinical Trial Progress In USA

MGC Pharmaceuticals Ltd (ASX, LSE: MXC, ‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development...
- Advertisement -spot_imgspot_img

European Cannabis Stocks Review: Akanda’s ‘Concerned Shareholders’ Oust All Directors Except CEO To Prevent ‘Potentially Irreparable Harm’ – More From Goodbody Health & Chill...

It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making...

Analysis Shows UK Market Could Grow To Over £1bn By 2026 As London Prepares To Host Europe’s Leading Cannabis Conference

ANALYSIS shows UK market could grow to over £1bn by 2026 as London prepares to host Europe’s leading cannabis...

Must read